According to a recent show on ABC presented by the good Dr Norman Swan the big pharmaceutical companies haven't been allocating resources and money to develop new antibiotics for many years - because - they sell too cheaply / too small a profit margin. A low margin is something we need to consider with Recce. Just shows you can't leave development of critical medicines wholly & solely to big pharma because it always has to be profit driven.
RCE Price at posting:
$1.04 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)